Penumbra, Inc. (PEN) · page 13 of 61
The slide highlights a contradiction between the company's regulatory pathway (510(k)) and its valuation relative to PMA-cleared peers.
Activist deck · peer_benchmark · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 3/3
paragraph 1/1 table 1/1 title 1/1
Components 3
paragraph data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1